Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis

Eyal Raskin, Anat Achiron, Ofira Zloto, Ron Neuman, Vicktoria Vishnevskia-Dai

Research output: Contribution to journalArticlepeer-review


Objective An association between uveitis and multiple sclerosis (MS) is well-established, but the actual nature of that association remains poorly understood. We sought to determine the association between the presence of a uveitis diagnosis prior to an MS diagnosis compared to no pre-existing uveitis diagnosis in MS patients. Methods Patients in whom the presentation of uveitis preceded the presentation of MS (study group) and patients with MS and no uveitis (control group) were randomly selected at a ratio of 1:3 from the Sheba Multiple Sclerosis Center computerized database. Results Eleven patients presented with uveitis prior to MS diagnosis (study group), and 31 randomly selected patients had MS without uveitis (control group). Only one patient in the study group deteriorated to EDSS 3 during the follow-up period, compared to 15 patients in the control group (9.1% vs 48.4%, P = 0.049). None of the patients in the study group reached EDSS 6 during the 10 years of follow-up compared to 6 (19.4%) patients in the control group (P = 0.194). Conclusions MS patients who presented with uveitis that preceded their neurological symptoms of MS demonstrated a clinically significant better neurological prognosis, than our MS patients with no uveitis.

Original languageEnglish
Article numbere0264918
JournalPLoS ONE
Issue number6 June
StatePublished - Jun 2022


Dive into the research topics of 'Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis'. Together they form a unique fingerprint.

Cite this